NEW YORK – Siemens Healthineers will in coming years phase out support for four legacy testing platforms as the company migrates customers to its newer Atellica instrument lineup that offers expanded automation capabilities.

纽约——随着西门子Healthineers将客户迁移到其更新的Atellica仪器系列中，该系列提供了扩展的自动化功能，西门子Healthineers将在未来几年逐步取消对四个传统测试平台的支持。

The Erlangen, Germany-based firm is ending support for all Advia Chemistry, Advia Centaur, Dimension, and Dimension Vista instruments. The company previously announced that it was ending the production and sale of those instruments, and it has begun notifying customers with affected systems about upcoming end-of-support dates after which it will no longer offer test materials or maintenance services for the affected platforms..

这家总部位于德国埃尔兰根的公司正在停止对所有Advia Chemistry、Advia Centaur、Dimension和Dimension Vista仪器的支持。该公司先前宣布停止生产和销售这些仪器，并已开始通知受影响系统的客户即将结束的支持日期，在此日期之后，它将不再为受影响的平台提供测试材料或维护服务。。

Lisa Rose, executive VP and head of Core Laboratory Solutions for Siemens' diagnostics business, said that the exact dates when customers lose support will vary depending on factors including the platforms that they are using, the countries where they operate their labs, and any contracts that they have with Siemens Healthineers..

西门子诊断业务执行副总裁兼核心实验室解决方案负责人丽莎·罗斯（LisaRose）表示，客户失去支持的确切日期将因各种因素而异，包括他们使用的平台、他们运营实验室的国家以及他们与西门子Healthineers签订的任何合同。。

Rose said that the company plans to end support for its Advia Chemistry instruments by the end of 2025. While the firm also will stop supporting its Dimension Vista instruments in Europe during 2025, she said that the firm extended the end-of-support date in the US by the end of 2026 due to the higher numbers of customers that are using those instruments and contracts with those customers, among other factors.

罗斯表示，该公司计划在2025年底结束对其Advia化学仪器的支持。虽然该公司也将在2025年停止在欧洲支持其Dimension Vista仪器，但她表示，由于使用这些仪器的客户数量增加以及与这些客户的合同等因素，该公司将美国的支持日期延长至2026年底。

The company expects to end support globally for its Advia Centaur and Dimension EXL instruments by the end of 2030..

该公司预计到2030年底，将停止对其Advia Centaur和Dimension EXL仪器的全球支持。。

'All these platforms have served our customers exceptionally well,' she said. 'We've had unique technologies that customers have preferred, one versus the other, but they all played in the same immunoassay, clinical chemistry space, so they were overlapping.'

她说，所有这些平台都为我们的客户提供了非常好的服务我们拥有客户喜欢的独特技术，但它们都在相同的免疫分析和临床化学领域发挥作用，因此它们是重叠的。”

The Advia Chemistry XPT, Advia 2400 Chemistry, and Advia 1800 Chemistry systems offer throughput of either 2,400 or 1,800 tests per hour, and the firm said on its website that the systems are designed to meet high-demand chemistry workloads. The company likewise said that the Advia Centaur XPT, XP, and CP Immunoassay systems are designed to help labs improve productivity to manage increasing demand, and those instruments offer throughput of 240 or 180 tests per hour..

Advia Chemistry XPT、Advia 2400 Chemistry和Advia 1800 Chemistry系统提供每小时2400或1800次测试的吞吐量，该公司在其网站上表示，这些系统旨在满足高需求的化学工作负载。。。

However, the Dimension EXL 200 and EXL with LM Integrated Chemistry systems, which integrate chemistry and immunoassay testing, are used to run up to 440 photometric tests, 187 integrated multisensory technology tests, and 167 immunoassays per hour. The Dimension Vista 1500 and 500 Intelligent Lab Systems, in comparison, also integrate immunoassays and clinical chemistry but those systems offer throughput of up to 2,000 or 1,000 tests per hour..

但是，集成了化学和免疫测定测试的Dimension EXL 200和带有LM集成化学系统的EXL用于每小时进行多达440次光度测试，187次集成多传感器技术测试和167次免疫测定。相比之下，Dimension Vista 1500和500智能实验室系统也集成了免疫分析和临床化学，但这些系统的吞吐量高达每小时2000或1000次测试。。

Siemens Healthineers began a transformation program in 2023 that included reducing the company's headcount and eliminating those four product lines in favor of transitioning customers to the Atellica instrument line. Company officials announced in November that its diagnostics business had become leaner, more profitable, and poised for growth and margin expansion as a result of the €450 million investment in those changes.

西门子Healthineers于2023年开始了一项转型计划，其中包括减少公司员工数量，取消这四条产品线，以便将客户转移到Atellica仪器生产线。公司官员于11月宣布，由于对这些变化进行了4.5亿欧元的投资，其诊断业务已变得更加精简，盈利能力更强，并有望实现增长和利润增长。

The firm ended sales of the Advia Chemistry, Advia Centaur, Dimension, and Dimension Vista instruments as part of that transition..

作为过渡的一部分，该公司终止了Advia Chemistry、Advia Centaur、Dimension和Dimension Vista仪器的销售。。

In November, Siemens Healthineers CEO Bernd Montag said during a conference call related to the company's Q4 earnings that its installed base of legacy instruments was expected to be a drag on the growth rate for the diagnostics business for the next two years. He noted, however, that the Atellica line has shown consistent growth, and the company expects rising revenues as customers update their instruments..

11月，西门子Healthineers首席执行官伯纳德·蒙塔格（Bernd Montag）在与该公司第四季度收益相关的电话会议上表示，预计其传统仪器的安装基数将拖累未来两年诊断业务的增长速度。然而，他指出，Atellica生产线已经显示出持续的增长，该公司预计随着客户更新其仪器，收入会增加。。

Rose said that Siemens Healthineers had built its instrument lineup through a series of acquisitions, and it is consolidating the platforms to the Atellica line using the technologies that the company has determined would be best to address evolving needs. She said that the Atellica lineup offers more automation features, onboard temperature and humidity controls, and consistent instrument operations and reagents that allow customers to simplify their operations, training, and inventory across lab or hospital systems..

Rose表示，西门子Healthineers通过一系列收购建立了其仪器阵容，并正在使用该公司确定的最能满足不断变化的需求的技术将平台整合到Atellica生产线。她说，Atellica产品线提供了更多的自动化功能、机载温度和湿度控制以及一致的仪器操作和试剂，使客户能够简化实验室或医院系统的操作、培训和库存。。

'We're a continuous improvement company, so we're constantly looking at how to improve these platforms and make them even better to serve our customer needs,' she said.

她说：“我们是一家持续改进的公司，因此我们一直在研究如何改进这些平台，使其更好地满足我们的客户需求。”。

Rose also noted that the Atellica line includes the simultaneous processing of reagents and samples to deliver rapid results, and the instruments have a menu of more than 50 assays with turnaround times of less than 20 minutes. She noted that Siemens is also expanding its menu through ongoing development of a series of assays for neurology, oncology, and cardiology applications, adding that the firm's Neurofilament Light Chain (NfL) assay to aid the management of multiple sclerosis is a recent example of the firm's work to offer more tests..

Rose还指出，Atellica系列包括同时处理试剂和样品以提供快速结果，并且这些仪器具有50多种检测的菜单，周转时间不到20分钟。她指出，西门子还通过正在进行的神经病学、肿瘤学和心脏病学应用的一系列检测方法的开发，扩大了其菜单，并补充说，该公司用于帮助管理多发性硬化症的神经丝轻链（NfL）检测方法是该公司提供更多检测的最新例子。。

The company's efforts to minimize energy and water consumption is also proving to be an advantage in certain markets, she said. Hospitals and labs in the EU, for example, are required to produce annual reports on their ecological sustainability efforts, while Australia introduced last year a national health and climate strategy for the development of a sustainable, climate-resistant health system..

她说，该公司努力将能源和水消耗降至最低，这在某些市场上也被证明是一种优势。例如，欧盟的医院和实验室需要就其生态可持续性工作提交年度报告，而澳大利亚去年推出了一项国家健康与气候战略，以发展可持续的、耐气候的卫生系统。。

Rose said that lab customers can be hesitant to change, although the company has specialists who can support those customers with assay changeovers and validation to make that transition easier. She declined to estimate what portion of Atellica buyers are existing customers, but company officials said by email that the Atellica line is now generating more than half of the diagnostics segment's revenues, with growth in the mid-teens..

罗斯说，实验室客户可能会犹豫是否要改变，尽管该公司有专家可以为这些客户提供检测转换和验证，以使这种转变更容易。她拒绝估计Atellica买家中有多少是现有客户，但公司官员通过电子邮件表示，Atellica产品线目前产生的收入占诊断部门收入的一半以上，增长速度在十几岁左右。。

Sheila Erpelding, VP of laboratory services for the Iowa-based Great River Health hospital system, said that her lab uses the Atellica Solution instrument with the automated Atellica Sample Handler component, and she previously worked in a lab with Vista chemistry and Centaur immunoassay platforms. While she said that she loved the simplicity of operating the Vista instrument, she also said that the Atellica's sample handling module has helped to improve processes for technicians, and she noted that the Atellica has simpler maintenance operations with reduced hands-on time compared to the Centaur instrument.

爱荷华州大河健康医院系统实验室服务副总裁希拉·埃尔佩尔丁（SheilaErpelding）说，她的实验室使用了带有自动Atellica样品处理器组件的Atellica解决方案仪器，她之前曾在Vista化学和Centaur免疫分析平台的实验室工作。虽然她说她喜欢操作Vista仪器的简单性，但她也说Atellica的样品处理模块有助于改进技术人员的流程，她指出，与Centaur仪器相比，Atellica的维护操作更简单，动手时间更少。

She also said that maintaining one instrument rather than two has been helpful..

她还说，维护一个而不是两个仪器是有帮助的。。

Erpelding said that her priority is to implement processes to help her techs be as efficient as possible, and she wants to eventually add a de-capper module to further automate the lab's processes.

埃尔佩尔丁说，她的首要任务是实施流程，以帮助她的技术人员尽可能提高效率，她希望最终添加一个封盖模块，以进一步自动化实验室的流程。

Siemens Healthineers secured US Food and Drug Administration clearance and CE marking for the Atellica Solution platform in 2017 and said by 2019 that the system had been helping it to win over new customers. The firm more recently, in July 2023, launched its Atellica CI Analyzer for low- to medium-volume labs, and the company had previously said that the launch would complete its updated immunoassay and clinical chemistry testing portfolio..

2017年，西门子Healthineers为Atellica解决方案平台获得了美国食品和药物管理局的批准和CE标志，并表示到2019年，该系统已帮助其赢得新客户。该公司最近于2023年7月推出了用于中低容量实验室的Atellica CI分析仪，该公司此前曾表示，该产品的推出将完成其更新的免疫测定和临床化学测试组合。。

The company also launched last year its Atellica Integrated Automation system to consolidate tasks and reduce manual steps that are performed by lab staff, and the firm launched this October the automation system for use with the Atellica CI Analyzer.

。

Rose said that Siemens Healthineers has already developed Atellica Solution versions of all of the clinically relevant assays that had been performed on the legacy instruments, although the firm is still working to secure regulatory clearances in the US and other markets for a few tests for the Atellica CI Analyzer.

Rose说，西门子Healthineers已经开发出Atellica解决方案版本，用于对传统仪器进行的所有临床相关检测，尽管该公司仍在努力确保美国和其他市场对Atellica CI分析仪的一些测试获得监管许可。

She noted that the company expects that those remaining assays will be available by the end-of-support dates for the legacy analyzers..

她指出，该公司预计剩余的检测方法将在遗留分析仪的支持日期结束时可用。。